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Abstract
Auto-antibodies (autoAbs) can result from excessive T follicular helper (Tfh) cell activity, while 
(Tfr) cells negatively regulate autoAb production. Interleukin-2 knockout (IL-2 KO) mice on the 
BALB/c background have elevated Tfh responses, produce autoAbs and develop lethal 
autoimmunity. We analyzed Tfh and Tfr cells in IL-2 KO mice on the C57Bl/6 (B6) genetic 
background. In B6 IL-2 KO mice the spontaneous formation of Tfh cells and Germinal Center 
(GC) B cells was greatly enhanced along with production of anti-DNA autoAbs. IL-2 has been 
reported to repress Tfr cell differentiation, however Tfr cells were not increased over wildtype 
(WT) levels in the B6 IL-2 KO mice. To assess Tfh and Tfr cell regulation of autoAb production in 
IL-2 KO mice, we generated IL-2 KO mice with a T cell-specific deletion of the master Tfh cell 
transcription factor Bcl6. In IL-2 KO Bcl6 conditional KO (2KO-Bcl6TC) mice, Tfh cells, Tfr 
cells and GC B cells were ablated. In contrast to expectations, autoAb IgG titers in 2KO-Bcl6TC 
mice were significantly elevated over auto-Ab IgG titers in IL-2 KO mice. Specific deletion of Tfr 
cells with Foxp3-cre Bcl6-flox alleles in IL-2 KO mice led to early lethality, before high levels of 
autoAbs could develop. We found IL-2+/+ Tfr cell deficient mice produce significant levels of 
autoAbs. Our overall findings provide evidence that Tfh cells are dispensable for high level 
production of autoAbs, and also reveal a complex interplay between Tfh and Tfr cells in autoAb 
production and autoimmune disease.
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Introduction
During an immune response, CD4 T helper cells can differentiate into several unique 
effector lineages that promote different immune responses via the secretion of distinct types 
of cytokines. T follicular helper (Tfh) cells are a CD4 T cell lineage whose major function is 
to help B cells form germinal centers (GCs) and produce high-affinity antibodies (Abs)
(reviewed in (1, 2)). Tfh cells are characterized by high level of expression of the chemokine 
receptor Cxcr5, which binds the chemokine Cxcl13 expressed in B cell follicles. Cxcl13, 
acting on Cxcr5, promotes migration of Tfh cells to the B cell follicle. Tfh cells have an 
activated effector T cell phenotype and express elevated Icos and PD-1. Tfh cells regulate 
memory B cell and plasma cell development, and thus Tfh cells control both the initiation as 
well as the outcome of the GC B cell response (1, 2). A key cytokine produced by Tfh cells 
is IL-21, a factor that potently promotes B cell activation and Ab secretion (1, 2). While Tfh 
cells are critical for the proper production of Ab, the over-production of Tfh cells can lead to 
autoimmunity as Tfh cells can help B cells to produce self-reactive Abs (1–10). Thus, the 
proper regulation of Tfh cell differentiation is essential for normal immune function as well 
as preventing autoimmune disease.
The Bcl6 transcriptional repressor protein is up-regulated in Tfh cells and is considered the 
master regulator for Tfh cells (11–13). Forced Bcl6 expression promotes differentiation of 
CD4 T cells into Tfh cells, whereas Bcl6-deficient T cells cannot differentiate into Tfh cells. 
A conditional knockout mouse for Bcl6, that we have developed, allows direct analysis of 
Bcl6 function in specific T cell populations (14).
A subpopulation of follicular T cells can act as suppressors of the GC response (15–21). 
These cells express both FoxP3 and Bcl6 and have been termed T follicular regulatory cells 
or “Tfr” cells. Tfr cells have a hybrid phenotype of Tfh cells and regulatory T cells (Tregs). 
Like Tfh cells, Tfr cells are dependent on Bcl6 and Cxcr5 for localization to the B cell 
follicle. Tfr cell functions are not well understood. In many model systems, Tfr cells 
suppress the number of Tfh cells and GC B cells during the immune response and also 
regulate affinity maturation of Abs (15–21). However, Tfr cells can also promote the GC and 
Ab response in certain model systems (22, 23). A popular model for the function of Tfr cells 
is that they limit the number of Tfh cells in the GC reaction or the amount of Tfh cell help, 
thus preventing excessive Tfh cell help to B cells (15, 24). In the absence of Tfr cells, 
excessive Tfh cell activity may lead to less stringent selection of high affinity B cell clones, 
leading to the expansion of low affinity B cell clones. Excessive Tfh cell activity may also 
promote the expansion of self-reactive B cells. Indeed, Tfr cells have an important role in 
maintaining tolerance during the B cell response and inhibiting the development of autoAbs 
(10, 23, 25–30).
Many autoimmune diseases are characterized by pathogenic self-reactive or autoreactive 
Abs (autoAbs)(31–33). AutoAb-mediated autoimmune diseases such as systemic lupus 
erythematosus (SLE), rheumatoid arthritis (RA), myasthenia gravis (MG) and autoimmune 
hemolytic anemia (AIHA) are a tremendous source of morbidity and mortality for the 
human population. Since Tfh cells can promote autoAb production (1-9), Tfh cells are 
considered as targets for developing therapies for autoAb-driven autoimmune diseases, 
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particularly SLE. However, the extent to which Tfh cells are required for autoAb generation 
is not clear. Tfh cells are not strictly required to help B cells make Abs (2, 14, 34), and in 
some model systems, autoAbs can even be produced in a T cell-independent manner (35, 
36). Understanding the interplay of Tfh and Tfr cells in the control of the autoAb response 
will expand our knowledge of the pathogenesis of diseases such as lupus and should lead to 
the development of new treatments.
Interleukin-2-deficient (IL-2 KO) mice develop a lethal autoimmune disease that varies with 
the genetic background of the mice. On a mixed 129/01a x C57BL/6 genetic background, 
IL-2 KO mice die early (at 9 weeks on average) and almost invariably develop severe colitis 
(37, 38). IL-2 KO mice on the BALB/c background die between 3-5 weeks from AIHA 
caused by the production of autoAbs to red blood cells (RBCs)(38, 39). In these mice, Tfh 
cells are increased in numbers as IL-2 suppresses Tfh cell differentiation by inhibiting Bcl6 
transcription (40–42). Tfr cell differentiation can be inhibited by IL-2 (25), although Tfr 
cells have not been examined previously in the IL-2 KO mice.
In the current study, we wondered if Tfr cells were elevated in IL-2 KO mice and if Tfh and 
Tfr cells played specific roles in autoAb production. We observed that unexpectedly, Tfr 
cells were not elevated even though Tfh cells were dramatically increased in IL-2 KO mice. 
Furthermore, we found that in IL-2 KO mice, high levels of autoAb can be produced 
independent of Tfh cells, and that low levels of Tfr cells can dramatically limit autoAb 
production.
Materials and Methods
Mice
IL-2 KO mice on the C57Bl/6 background and MyD88 KO mice on the C57Bl/6 
background were obtained from Jackson labs. CD4-cre Bcl6-flox and Foxp3-cre Bcl6-flox 
mice were described previously (14, 23). Crossing of strains to produce IL-2 KO CD4-cre 
Bcl6-flox (2KO-Bcl6TC), IL-2 KO Foxp3-cre Bcl6-flox (2KO-Bcl6FC) and IL-2 KO 
MyD88 double KO (IL2-MyD88) DKO mice used published genotyping protocols (14, 23), 
as well as genotyping protocols from Jackson labs. All IL-2 KO mice were bred from IL-2+/
− parents. IL-2+/+ WT littermates were used as controls for IL-2 KO, 2KO-Bcl6TC, 2KO-
Bcl6FC and IL2-MyD88 DKO mice. Both male and female mice of 5-10 weeks old were 
analyzed. Mice were bred under specific pathogen-free conditions at the laboratory animal 
facility at IUSM and were handled according to protocols approved by the IUSM Animal 
Use and Care Committee.
Flow cytometry reagents and cell staining for flow cytometry
Cell suspensions from spleens were prepared and filtered through a 40-μm cell strainer 
(Fisherbrand). Cells were washed and diluted in PBS with 1% FBS and were stained with Fc 
block (BioXCell) for 5 min, followed by surface staining for the indicated markers. 
Following labelled Abs were used: anti-CXCR5 (L138D7), anti-PD-1 (29F.1A12), anti-CD4 
(RM4-5), anti-Foxp3 (MF-14), anti-CD38 (90) and anti-B220 (RA3-6B2) were obtained 
from BioLegend; GL7 (GL7) was purchased from BD Pharmingen. For intracellular 
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staining, after surface markers were stained, cells were fixed and stained with anti-Foxp3, 
eBioscience intracellular kit was used. All samples were acquired on an LSR2 flow 
cytometer (Becton Dickonson) and analyzed with FlowJo software.
Anti-dsDNA titer analysis
Anti-dsDNA IgA and IgG titers were determined by ELISA, as previously reported (14). 
Briefly, 96-well Nunc-Immuno plates (Sigma-Aldrich) were coated overnight at 4°C with 
salmon sperm DNA passed through 45 μm filter (Invitrogen). Wells were blocked with 1% 
BSA for 1.5 hours. Diluted serum samples were applied. ELISA plates were incubated for 1 
hour at 37°C for anti-dsDNA Ab detection. Peroxidase-conjugated anti-mouse IgA or anti-
mouse IgG (Sigma-Aldrich) was used as secondary Ab. Anti-dsDNA ELISA plates were 
washed extensively after each incubation to minimize high background signals.
Autoantibody Array
Autoantibody reactivities against a penal of autoantigens were measured using an 
autoantigen microarray platform developed by University of Texas Southwestern Medical 
Center (https://microarray.swmed.edu/products/category/protein-array/). Serum samples 
were incubated with the autoantigen array and the autoantibodies binding to the antigens on 
the array were detected with laser wavelengths 532nm (cy3 labeled anti-IgG), generating 
Tiff images. Genepix Pro 6.0 software was used to analyze the image and generate a .GPR 
file (GenePix Results format). Signal-to-noise ratio (SNR= (Foreground Median-
Background Median)/sd(Background)) is used as a quantitative measure of the ability to 
resolve true signal from background noise. A higher SNR indicates higher signal over 
background noise. SNR equal or bigger than 3 are considered true signal from background 
noise.
Pristane administration.
Mice were given a single i.p. injection of 0.5 ml Pristane (Sigma-Aldrich) at 12 weeks of 
age. After 4 months, mice were sacrificed. The presence of anti-dsDNA antibodies in the 
serum was tested by ELISA.
Statistical Analysis.
All data analysis was done using Prism Graphpad software. Unless otherwise stated, Student 
t test or ANOVA with Tukey post hoc analysis were used. Only significant differences (P < 
0.05) are indicated in Figures.
Results
Tfh cells but not Tfr cells are increased in the absence of IL-2 in vivo.
In order to analyze the role of Tfh and Tfr cells in the IL-2 KO, we obtained IL-2 KO mice 
on the C57Bl/6 (B6) background, since this strain was genetically compatible with most 
conditional KO strains that are also on the B6 background. We found that IL-2 KO mice on 
the B6 background in our facility were healthier than reported for IL-2 KO mice on the 
BALB/c background (38, 39, 43). In our colony, most B6 IL-2 KO mice live longer than 5 
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weeks and have a lifespan more similar to what was seen with IL-2 KO on the mixed 129-
O1a x C57Bl/6 background (37, 38). However, the B6 background IL-2 KO mice were 
nonetheless smaller than wild-type (WT) and IL-2+/− littermates, had a sickly appearance, 
had enlarged spleens (Supp. Fig 1) and were infertile. To determine if loss of IL-2 led to 
higher Tfh and Tfr cells in this B6 background IL-2 KO strain, we conducted flow 
cytometry analysis (Fig. 1). As shown in Fig. 1A–B, we observed a roughly 7-fold increase 
in Tfh cells in unimmunized mice IL-2 KO mice compared to unimmunized wild-type (WT) 
mice. Even more striking was the large increase (~15-fold) in PD-1+ populations, indicating 
a high level of activated CD4 T cells in the un-manipulated IL-2 KO mice. In contrast to Tfh 
cells, Tfr cells were not significantly increased in the IL-2 KO (Fig. 1C–D), though IL-2 has 
been shown to inhibit both Tfh and Tfr cell development (25, 40–42). The lack of increase in 
Tfr cells was not due to a general loss of Treg cells in these mice, as total numbers of 
Foxp3+ CD4+ T cells were not significantly different from WT (Supp. Fig. 1). This result is 
different from what was seen with IL-2 KO mice on the BALB/c background, which show a 
marked depletion of Tregs (44). The more severe phenotype of the BALB/c IL-2 KO mice 
may relate to the significant loss of Tregs seen in that strain. Even though overall numbers of 
Tregs were not significantly decreased in the B6 IL-2 KO, there was a 3-fold increase in 
PD-1+ Tregs (Fig. 1C–D), suggesting more Treg activation in the IL-2 KO background. Our 
results also show that while IL-2 can be inhibitory for Tfr cell differentiation (25), in the 
IL-2 KO model of autoimmunity, IL-2 is also required for Tregs to fully mature into Tfr 
cells.
Deletion of Tfh and Tfr cells in IL-2 KO mice.
To test the functional role of Tfh cells in the autoimmune disease and in autoAb production 
in the IL-2 KO mice, we mated the mice to the Bcl6-flox CD4-cre mouse strain (termed here 
Bcl6TC), which is unable to produce follicular T cells due to deletion of the Bcl6 gene in 
CD4 and CD8 T cells (14, 45). We therefore produced double mutant mice that we termed 
2KO-Bcl6TC mice. The 2KO-Bcl6TC mice show a similar disease profile to IL-2 KO mice: 
both types of mice are smaller in size and both have enlarged spleens, multi-organ 
inflammation and similarly shortened lifespans (Supp. Figs. 1–2 and data not shown). We 
then examined the Tfh and GC B cell compartments in 2KO-Bcl6TC mice, and found both 
Tfh and GC B cells were completely ablated (Figure 2). This indicates first, that even in an 
IL-2-deficient environment, Bcl6 is still required for Tfh cell development. Second, these 
data show that Tfh cells do not correlate with overall disease in the IL-2 KO model.
Tfh cell-independent production of autoAbs.
We next asked whether Tfh cells were required for autoAbs in IL-2 KO mice and first 
measured anti-double stranded DNA Abs by ELISA (Figure 3). As expected, IL-2 KO mice 
had elevated levels of both IgG and IgA anti-DNA Abs compared to WT. Unexpectedly, loss 
of Tfh cells in 2KO-Bcl6TC mice led to significantly higher titers of both IgG (~3-fold 
higher) and IgA (~10-fold higher) anti-DNA Abs than seen in the IL-2 KO mice. To further 
analyze autoAbs in these mice, we used an auto-antigen (autoAg) microarray assay system 
to screen for IgG autoAbs to a panel of mouse protein antigens (Ags). Out of 94 autoAgs 
analyzed on the microarray, 17 autoAgs showed a significant difference in IgG reactivity 
between WT, IL-2 KO and 2KO-Bcl6TC groups (Fig. 4A). All 17 of these autoAgs showed 
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a significantly higher Ab binding score for the 2KO-Bcl6TC sera over WT and IL-2 KO. 
Surprisingly, IL-2 KO sera showed little increase in autoAg binding over WT (Fig. 4A–B). 
These data showed that high levels of autoAbs could be produced in the absence of Tfh 
cells. To test that this result wasn’t unique to the IL-2 KO model, we used the pristane model 
of lupus (46, 47) to test the generation of anti-DNA Abs in WT and Bcl6TC mice. As shown 
in Figure 5A, WT and Bcl6TC mice both produced substantial levels of anti-DNA IgG after 
pristane immunization, although the production of anti-DNA IgA was lower in Bcl6TC 
mice. Thus, significant levels of autoreactive IgG can be produced in the absence of Tfh 
cells, though production of autoreactive IgA appears to require Tfh cell help.
Regulation of autoAbs by Tfr cells.
We then wondered if the higher titers of autoAbs in the 2KO-Bcl6TC mice were due to loss 
of Tfr cells that would normally inhibit development of strong autoAb responses. To test this 
hypothesis, we mated IL-2 KO mice to Bcl6-flox Foxp3-cre mice that are specifically 
deficient in Tfr cells, to generate double mutant (2KO-Bcl6FC) mice also on the B6 
background. In 2KO-Bcl6FC mice, we found that deletion of Bcl6 in Tregs and the loss of 
Tfr cells dramatically worsened the early lethality in the B6 background IL-2 KO mice. The 
average lifespan of 2KO-Bcl6FC mice was 3.5 weeks (Fig. 6A), and thus much shorter than 
the B6 IL-2 KO mice, which typically lived past 10 weeks of age. We analyzed sera from 
three 2KO-Bcl6FC mice that lived to 5 weeks for anti-DNA IgM and IgG levels by dsDNA 
ELISA (Fig. 6B–C). The 2KO-Bcl6FC mice had significant less anti-DNA IgM (Fig. 6B), 
but had a trend toward increased anti-DNA IgG (Fig. 6C) Abs over IL-2 KO mice. We then 
used the autoAg microarray assay system to screen for IgG autoAbs, but did not observe 
significant differences in autoAbs between in IL-2 KO and 2KO-Bcl6FC mice (data not 
shown). 2KO-Bcl6FC mice also did not show significantly more organ inflammation than 
age-matched IL-2 KO mice (data not shown). Thus, the early death of 2KO-Bcl6FC mice 
cannot be explained by more autoAbs or stronger inflammatory disease. At the same time, 
the shortened lifespan of 2KO-Bcl6FC mice likely forestalled more severe autoimmune 
disease as autoAbs and inflammation typically develops with increased age. To better 
understand the role of Tfr cells in repressing autoAb responses, we analyzed the 
development of autoAbs in IL-2+/+ Tfr cell-deficient Bcl6FC mice (Fig. 7). Bcl6FC mice 
are healthy, fertile, have a normal lifespan (23). We found that significantly increased titers 
of anti-DNA IgG develop in older Bcl6FC mice compared to WT controls (Fig. 7A). 
Additionally, aged Bcl6FC mice produced significant levels of anti-DNA anti-IgA, whereas 
WT mice produced undetectable levels (Fig. 7B). This finding further supports a role for Tfr 
cells controlling IgA production (23). We further tested autoAbs in Bcl6FC mice by autoAg 
microarray, and found higher levels of IgM Abs to several autoAgs Fig. (7C). These data 
show that in our Bcl6FC mouse model in our mouse colony, Tfr cells have a significant role 
in maintaining Ab self-tolerance, consistent with recent findings using different models of 
Tfr cell deficiency (26, 27).
Discussion
In this study, we have used the IL-2 KO mouse model of autoimmunity to probe the roles of 
Tfh cells and Tfr cells in the development of autoAbs. Tfh cells are required for the germinal 
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center reaction and the production of high affinity antibodies to antigen, and excessive 
development of Tfh cells can promote autoAb production. Tfr cell functions are less well 
defined due to conflicting data on whether Tfr cells have a suppressive or helper function in 
the GC (20). However, there is general consensus that Tfr cells repress the development of 
autoAbs (23, 25–30). In our work here analyzing the IL-2 KO model of autoimmunity, we 
found unexpectedly that Tfh cells were not required for the production of high levels of 
autoAbs, and further that Tfr cells appear to potently inhibit the magnitude of autoAb 
responses.
Previous work on the IL-2 KO model showed strong differences depending on the genetic 
background. On a mixed 129/01a x C57BL/6 background, IL-2 KO mice die at an early age, 
most likely from severe colitis (37, 38). AutoAbs specific for colon cells were detected in 
this mixed background IL-2 KO (37). In BALB/c IL-2 KO mice, high levels of autoAbs to 
RBCs lead to severe AIHA and much earlier death than on a mixed background (38, 39). In 
BALB/c IL-2 KO mice, conventional CD4+ Tfh cells are elevated, as well as an unusual 
CD8+ Tfh-like population with B cell helper activity (39). Both CD4+ and CD8+ cells 
contribute to autoAb production and autoimmune disease in the BALB/c IL-2 KO model 
(39). Our B6 IL-2 KO mice live longer than what has been reported for BALB/c IL-2 KO 
mice, and to a similar age as reported for IL-2 KO mice on a mixed background. We did not 
observe significant development of colitis in our B6 background IL-2 KO mice, but did find 
significant inflammatory infiltration in the lung and liver and kidney (Supp. Fig. 2). Tfh cells 
were not analyzed in the mixed IL-2 KO mice but we observed that Tfh cells were elevated 
similarly to what was reported for BALB/c IL-2 KO mice. In terms of autoAb production, 
B6 IL-2 KO produced very little if any autoAbs to self-proteins but developed significant 
levels of anti-double stranded DNA Abs. We did not assess anti-RBC autoAbs directly, 
however we did observe apparent anemia (decreased hematocrit) in the B6 IL-2 KO mice 
(data not shown). Overall, the B6 background IL-2 KO mice had a somewhat different 
phenotype from both the mixed background and BALB/c background mice, although there 
are many similarities (Supp. Table 1). How many of these differences is due to the pure B6 
background or from the conditions of different mouse colonies and related effects such as 
elimination of specific pathogens and microbiota is not clear.
Our original hypothesis for this study was that the increased Tfh cells were critical for 
promoting the autoimmune disease in the IL-2 KO mice by driving formation of autoAbs. 
However, when we deleted Tfh cells from the B6 IL-2 KO background, the 2KO-Bcl6TC 
mice had a similar disease phenotype as the B6 IL-2 KO strain (Supp. Fig. 1–2, Supp. Table 
1). Note that both CD4+ Tfh cells and CD8+ Tfh-like cells are dependent on Bcl6 for 
development and are deleted in Bcl6TC cKO mice (14, 45). Even more unexpected than the 
similar disease phenotype of IL-2 KO mice and 2KO-Bcl6TC mice was that despite loss of 
Tfh cells, 2KO-Bcl6TC mice had higher levels of not only anti-DNA IgG autoAbs but also 
IgG autoAbs to self-proteins. Among other things, these data show that Tfh cells are not 
required for the robust production of IgG autoAbs in B6 IL-2 KO mice. Our data contrasts 
with data from the BALB/c background, where depletion of either CD4 or CD8 T cells led 
to lower total Ig, decreased anti-RBC Abs and improved overall survival of the mice (39). 
However, it seems likely that non-Tfh cells drive autoAb production in both the B6 and 
BALB/c IL-2 KO models.
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The strongly increased levels of autoAbs in 2KO-Bcl6TC mice showed that a population of 
T cells that would normally suppress autoAb production was removed by the loss of T cell-
specific Bcl6. The major candidates for such cells are Tfh cells and Tfr cells. While in 
principle, Tfh cells could play a suppressive role in driving autoAb generation, perhaps by 
diverting autoreactive B cells into the GC reaction and mutating them away from auto-
reactivity, such a mechanism is speculative. A more likely explanation is that loss of Tfr 
cells in 2KO-Bcl6TC mice led to a loss of suppression of auto-reactive B cells. We tested 
this idea by generating 2KO-Bcl6FC mice, creating an IL-2 KO background where Tfr cells 
are deleted without affecting Tfh cells. 2KO-Bcl6FC mice had significantly worse disease 
than 2KO-Bcl6TC mice, with markedly stunted growth and 80% lethality by 4 weeks of age. 
However, 2KO-Bcl6FC mice did not have increased levels of autoAbs nor did they have 
increased organ inflammation compared to IL-2 KO mice, indicating a more complex 
pathogenesis in these mice. BALB/c IL-2 KO mice have a loss of Treg function as well as a 
loss of Treg cell numbers that correlates with autoimmune disease and that can be restored 
by IL-2 treatment (44). However, we did not observe decreased Treg cells in the B6 IL-2 KO 
or IL2-Bcl6TC mice, and the normal numbers of Tregs in these mice correlated with less 
severe disease than in BALB/c IL-2 KO mice. In the 2KO-Bcl6FC mice, we hypothesize that 
loss of Bcl6 expression coupled with loss of IL-2 signals led to a disabled, depleted or 
destabilized the overall Treg cell population. A loss of Tregs or Treg function coupled with 
normal T effector cells can promote severe inflammatory disease and/or autoimmune 
disease. We did not detect stronger inflammatory disease or autoAb production in the 2KO-
Bcl6FC mice, although the early death and stunted growth of these mice made pathology 
difficult to elucidate.
While deletion of Tfh cells did not inhibit the production of anti-DNA autoAbs in the IL-2 
KO mice, we did observe that deletion of MyD88 in the IL-2 KO mice did block anti-DNA 
autoAbs (Supp. Fig. 3). IL-2-MyD88 double KO mice also appeared to be healthier than 
IL-2 KO mice and developed to a normal size (data not shown). MyD88 is a downstream 
signaling protein for TLR molecules, and MyD88-dependent TLR signals are known to 
promote inflammation and amplify autoimmunity (48). Our data indicate that innate signals, 
likely nucleic acids released from dead cells (49), as well as commensal-derived TLR-
ligands (50), help to promote the formation of autoimmune disease and autoAbs in the IL-2 
KO mice. Strikingly, TFR cells were increased in IL-2-MyD88 double KO mice over WT 
levels (Supp. Fig. 3), suggesting that in a less pro-inflammatory environment, IL-2 is indeed 
inhibitory for Tfr cell generation. In other words, the loss of Tfr cells observed in IL-2 KO 
mice maybe due to increased destabilization of the Treg population from inflammatory 
cytokines.
In summary, our studies on the IL-2 KO model of autoimmunity have generated new 
insights into the roles of Tfh and Tfr cells in controlling autoAbs formation and in the role of 
IL-2 in regulating Tfr cell differentiation. Further work is needed to understand more 
completely how Tfr cells control autoimmunity and the function of Tfr cells in IL-2 KO 
mice.
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Figure 1. Spontaneous and strong Tfh cell but not Tfr cell development in IL2 KO mice.
Naïve 10 weeks old wild-type (WT) and IL-2 KO mice were used to analyzed Tfh and Tfr 
responses. Spleens were analyzed for the indicated cell populations by flow cytometry. 
Representative flow cytometric dot plots for each cell staining are shown along with graphs 
showing average % of cells as a fraction of parental cell population and total yield of cells. 
(A-B) Analysis of CD4+ Foxp3-T cells as PD-1+Cxcr5-, PD-1+Cxcr5+ (Tfh) PD-1-Cxcr5+ 
and PD-1-Cxcr5-populations. (B) Tfh cells and non-Tfh cell populations are quantitated as a 
percentage of CD4+Foxp3-T cells, and absolute number per spleen. (C-D) Analysis of 
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CD4+ Foxp3+T cells as PD-1+Cxcr5-, PD-1+Cxcr5+ (Tfr) PD-1-Cxcr5+ and PD-1-Cxcr5-
populations. (D) Tfr cells are quantitated as a percentage of CD4+Foxp3+ T cells, and 
absolute number per spleen. P values were calculated by t test where * p < 0.05, ** p < 0.01, 
*** p < 0.0001. N = 4 - 6 mice, and each experiment was repeated 2 times.
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Figure 2. Loss of Tfh and GCB cells in 2KO-Bcl6TC mice.
Naïve 10 week old WT, IL-2 KO, Bcl6TC (CD4-cre Bcl6-flox cKO) and 2KO-Bcl6TC (IL-2 
KO and CD4-cre Bcl6-flox cKO) mice were used to analyzed germinal center responses. 
Spleens were analyzed for the indicated cell populations by flow cytometry. Representative 
flow cytometric dot plots for each cell staining are shown along with graphs showing 
average % of cells as a fraction of parental cell population and total yield of cells. (A) – (B) 
Analysis of CD4+ PD-1+Cxcr5+ follicular T cells. Follicular T cells are quantitated as a 
percentage of CD4+ T cells, and absolute number per spleen. (C) – (D) Analysis of 
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B220+CD38-GL7+GCB cells. GCB cells are quantitated as a percentage of B220+ cells, 
and absolute number per spleen. P values were calculated by t test where * p < 0.05, ** p < 
0.01, *** p < 0.0001. N = 4 - 6 mice, and each experiment was repeated 2 times.
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Figure 3. Increased anti-DNA Abs in 2KO-Bcl6TC mice.
Naïve 10 weeks old WT, IL-2 KO, Bcl6TC and 2KO-Bcl6TC mice were used to analyzed 
serum Ab responses for reactivity to double stranded (ds) DNA. Bar graphs on left show 
normalized results over all experiments where OD values at 1:25 dilutions of serum are 
normalized relative to the average OD value for IL-2 KO serum, which is set to 1.0 for each 
experiment. Line graphs on right show sample ELISA results with titrations for individual 
sets of sera. Serum was tested for (A) anti-dsDNA IgG and (B) anti-dsDNA IgA. P values 
were calculated by t test where * p < 0.05, ** p < 0.01, *** p < 0.0001. N = 4 - 6 mice, and 
each experiment was repeated at least 3 times.
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Figure 4. Increased autoAbs in 2KO-Bcl6TC mice.
Serum from naïve 10 weeks old WT, IL-2 KO and 2KO-Bcl6TC mice was analyzed for IgG 
reactivity to an autoantigen (autoAg) microarray. (A) Heat map of 17 autoAgs with 
significantly higher reactive IgG between WT, IL-2 KO and 2KO-Bcl6TC mice based on the 
microarray score and multi-comparison statistical analysis. 17 autoAgs out of 94 autoAgs 
tested showed a significant difference in IgG reactivity between the 3 groups, and all 17 
showed a higher score for the 2KO-Bcl6TC sera. (B) Graphs of selected anti-autoAg IgG 
scores for anti-beta-2 microglobulin, anti-U1-snRNP and anti-Histone H3 taken from the 
autoAg array data. P values were calculated by t test where * p < 0.05, ** p < 0.01, *** p < 
0.0001. N = 4 - 6 mice.
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Figure 5. Anti-DNA Abs were not affected by the deletion of germinal centers in pristane-
induced lupus model.
Four months after a single 0.5 mL pristane i.p. injection, serum samples were collected from 
control WT and Bcl6TC mice for anti-dsDNA antibody detection by ELISA. (A) Anti-
dsDNA IgG and (B) anti-dsDNA IgA titers are shown. The X-axis labels are dilution factors. 
Data shown as mean ± SEM, n=5. Data are pooled from two independent experiments.
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Figure 6. Early death of 2KO-Bcl6FC mice and autoAb production.
(A) Survival curve for IL-2 KO and 2KO-Bcl6FC (IL-2 KO Foxp3-cre Bcl6-flox cKO) mice 
over time. A Gehan-Breslow-Wilcoxon test was used to measure the statistical difference 
between the samples. (B-C) Serum samples were collected from 5 week old WT, IL-2 KO, 
Bcl6FC and 2KO-Bcl6FC mice for anti-dsDNA antibody detection by ELISA. (B) Anti-
dsDNA IgM and (B) anti-dsDNA IgG titers are shown. The X-axis labels are dilution 
factors. Data shown as mean ± SEM, n=4 for WT, IL-2 KO, Bcl6FC and n=3 for 2KO-
Bcl6FC. P values were calculated by T-test where * p < 0.05, ** p < 0.01, *** p < 0.0001.
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Figure 7. Increased auto-Abs in Bcl6FC mice.
Serum from naïve WT and Bcl6FC mice was used to analyzed for anti-dsDNA Abs by 
ELISA and autoAg microarray. (A-B) Serum from 20 week old mice was tested for (A) anti-
dsDNA IgG and (B) anti-dsDNA IgA. P values were calculated by t test where * p < 0.05, 
** p < 0.01, *** p < 0.0001. N = 6 mice, experiment was repeated at 2 times. (C) Serum 
from 5 week old mice was tested for anti-autoAg IgG by microarray. 38 autoAgs out of 118 
autoAgs tested showed a significant difference in IgG reactivity between WT and Bcl6FC, 
and all 38 showed a higher score for the Bcl6FC sera. All Graphs show selected anti-autoAg 
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IgG scores for anti-collagen V, anti-Hmgb1, anti-DNA polymerase beta and anti-Histone 
H2B taken from the autoAg array data. P values were calculated by t test where ** p < 0.01. 
N = 4 mice.
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